Abbott Laboratories operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Abbott Laboratories with three other
companies in this sector in the United States:
sales of $32.75 billion
of which 100%
was Pharmaceutical Products),
Bristol-Myers Squibb Company
Eli Lilly and Company
of which 48%
was Human pharmaceutical products - Endocrin).
During the year ended December of 2018, sales at
Abbott Laboratories were $30.58 billion.
increase of 11.6%
versus 2017, when the company's sales were $27.39 billion.
This was the fourth straight year of sales growth at Abbott Laboratories.
Sales of Diagnostics Products saw an increase
that was more than double the company's growth rate: sales were up
33.5% in 2018, from
$5.62 billion to $7.50 billion.
Abbott Laboratories also saw significant increases in sales in
Other (up 20.8% to $2.00 billion)